Skip to content
10-K

Annual Report

Amarantus Bioscience Holdings, Inc.

0001213900-16-013437

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · May 11, 2016 67.51M sh
Capex FY 2015 · Dec 31, 2015 $10K
Capex FY 2015 · Dec 31, 2014 $181K
Cash And Equivalents FY 2015 · Dec 31, 2015 $176K
Cash And Equivalents FY 2015 · Dec 31, 2014 $214K
Stockholders Equity FY 2015 · Dec 31, 2015 −$8.69M
Stockholders Equity FY 2015 · Dec 31, 2014 −$4.07M
Current Liabilities FY 2015 · Dec 31, 2015 $16.19M
Current Liabilities FY 2015 · Dec 31, 2014 $6.33M
Total Liabilities FY 2015 · Dec 31, 2015 $17.31M
Total Liabilities FY 2015 · Dec 31, 2014 $6.33M
Current Assets FY 2015 · Dec 31, 2015 $828K
Current Assets restated FY 2015 · Dec 31, 2014 $616K
Total Assets FY 2015 · Dec 31, 2015 $11.77M
Total Assets FY 2015 · Dec 31, 2014 $2.26M
Sga Expense FY 2015 · Dec 31, 2015 $11.57M
Sga Expense FY 2015 · Dec 31, 2014 $7.59M
Rd Expense FY 2015 · Dec 31, 2015 $13.26M
Rd Expense FY 2015 · Dec 31, 2014 $13.76M
Net Income FY 2015 · Dec 31, 2015 −$25.21M
Net Income FY 2015 · Dec 31, 2014 −$27.28M
Operating Income FY 2015 · Dec 31, 2015 −$24.82M
Operating Income FY 2015 · Dec 31, 2014 −$21.35M